zanubrutinib,Ibrutinib
abbvie,beigene,janssen
['lymsm', 'zanubrutinib', 'cll', 'leusm', ' ibru']
zanubrutinib pfs, orr is superior to ibrutinib for relapsed/refractory cll/sll #ash22 #ash2022 #leusm #lymsm 
Healthcare publisher of oncology focused articles, videos, panel discussions, and much more that run the gamut of oncology care and management.